Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 26;187(26):7621-7636.e19.
doi: 10.1016/j.cell.2024.11.016. Epub 2024 Dec 12.

Regulation of human interferon signaling by transposon exonization

Affiliations

Regulation of human interferon signaling by transposon exonization

Giulia Irene Maria Pasquesi et al. Cell. .

Abstract

Innate immune signaling is essential for clearing pathogens and damaged cells and must be tightly regulated to avoid excessive inflammation or autoimmunity. Here, we found that the alternative splicing of exons derived from transposable elements is a key mechanism controlling immune signaling in human cells. By analyzing long-read transcriptome datasets, we identified numerous transposon exonization events predicted to generate functional protein variants of immune genes, including the type I interferon receptor IFNAR2. We demonstrated that the transposon-derived isoform of IFNAR2 is more highly expressed than the canonical isoform in almost all tissues and functions as a decoy receptor that potently inhibits interferon signaling, including in cells infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Our findings uncover a primate-specific axis controlling interferon signaling and show how a transposon exonization event can be co-opted for immune regulation.

Keywords: alternative splicing; innate immunity; transposable elements; type I IFN.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests G.I.M.P. and E.B.C. have filed a provisional patent related to this work (PCT application no. PCT/US2023/066767).

Update of

References

    1. Hanada T, and Yoshimura A (2002). Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev. 13, 413–421. 10.1016/s1359-6101(02)00026-6. - DOI - PubMed
    1. Bengtsson AA, and Rönnblom L (2017). Role of interferons in SLE. Best Pract. Res. Clin. Rheumatol 31, 415–428. 10.1016/j.berh.2017.10.003. - DOI - PubMed
    1. Rönnblom L, and Eloranta M-L (2013). The interferon signature in autoimmune diseases. Curr. Opin. Rheumatol 25, 248–253.10.1097/BOR.0b013e32835c7e32. - DOI - PubMed
    1. Brito-Zerón P, Baldini C, Bootsma H, Bowman SJ, Jonsson R, Mariette X, Sivils K, Theander E, Tzioufas A, and Ramos-Casals M (2016). Sjögren syndrome. Nat Rev Dis Primers 2, 16047. 10.1038/nrdp.2016.47. - DOI - PubMed
    1. Roelofs MF, Wenink MH, Brentano F, Abdollahi-Roodsaz S, Oppers-Walgreen B, Barrera P, van Riel PLCM, Joosten LAB, Kyburz D, van den Berg WB, et al. (2009). Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA). Ann. Rheum. Dis 68, 1486–1493. 10.1136/ard.2007.086421. - DOI - PubMed

MeSH terms

LinkOut - more resources